News Details
Glaxo Smith Kline (BIOC.CA) Reports 9 Months Consolidated Results
30/11/2022
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Consolidated Period : From 01/01/2022 To 30/09/2022
Net Profit : 920,727,901
F/S Consolidated Period : From 01/01/2021 To 30/09/2021
Net Comparative Profit : 70,118,404
Audit Status : Reviewed
Source : Glaxo Smith Kline